117 related articles for article (PubMed ID: 30941964)
1. Comparison of 10 prognostic staging systems in patients with advanced hepatocellular carcinoma.
Wang L; Xian Y; Yang Z
J BUON; 2019; 24(1):150-157. PubMed ID: 30941964
[TBL] [Abstract][Full Text] [Related]
2. Comparison of clinical staging systems in predicting survival of hepatocellular carcinoma patients receiving major or minor hepatectomy.
Chen TW; Chu CM; Yu JC; Chen CJ; Chan DC; Liu YC; Hsieh CB
Eur J Surg Oncol; 2007 May; 33(4):480-7. PubMed ID: 17129701
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of unresectable hepatocellular carcinoma: comparison of seven staging systems (TNM, Okuda, BCLC, CLIP, CUPI, JIS, CIS) in a Chinese cohort.
Zhang JF; Shu ZJ; Xie CY; Li Q; Jin XH; Gu W; Jiang FJ; Ling CQ
PLoS One; 2014; 9(3):e88182. PubMed ID: 24609114
[TBL] [Abstract][Full Text] [Related]
4. Validation and ranking of seven staging systems of hepatocellular carcinoma.
Chen ZH; Hong YF; Lin J; Li X; Wu DH; Wen JY; Chen J; Ruan DY; Lin Q; Dong M; Wei L; Wang TT; Lin ZX; Ma XK; Wu XY; Xu R
Oncol Lett; 2017 Jul; 14(1):705-714. PubMed ID: 28693224
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
[TBL] [Abstract][Full Text] [Related]
6. Comparison of four current staging systems for Chinese patients with hepatocellular carcinoma undergoing curative resection: Okuda, CLIP, TNM and CUPI.
Lu W; Dong J; Huang Z; Guo D; Liu Y; Shi S
J Gastroenterol Hepatol; 2008 Dec; 23(12):1874-8. PubMed ID: 18752560
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of predictive value of Okuda, TNM, CLIP and JIS staging systems for hepatocellular carcinoma patients].
Lee SW; Han SY; Kim KT; Baek YH; Koh IY; Kim BH; Park EH; Jang JS; Roh MH; Choi JC
Korean J Hepatol; 2007 Jun; 13(2):196-207. PubMed ID: 17585193
[TBL] [Abstract][Full Text] [Related]
8. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
Li X; Dong M; Lin Q; Chen ZH; Ma XK; Xing YF; Wan XB; Wen JY; Wei L; Chen J; Wu XY
Asia Pac J Clin Oncol; 2013 Mar; 9(1):86-92. PubMed ID: 23279888
[TBL] [Abstract][Full Text] [Related]
9. Advanced hepatocellular carcinoma: which staging systems best predict prognosis?
Huitzil-Melendez FD; Capanu M; O'Reilly EM; Duffy A; Gansukh B; Saltz LL; Abou-Alfa GK
J Clin Oncol; 2010 Jun; 28(17):2889-95. PubMed ID: 20458042
[TBL] [Abstract][Full Text] [Related]
10. Prospective validation of the Chinese University Prognostic Index and comparison with other staging systems for hepatocellular carcinoma in an Asian population.
Chan SL; Mo FK; Johnson PJ; Liem GS; Chan TC; Poon MC; Ma BB; Leung TW; Lai PB; Chan AT; Mok TS; Yeo W
J Gastroenterol Hepatol; 2011 Feb; 26(2):340-7. PubMed ID: 21261725
[TBL] [Abstract][Full Text] [Related]
11. Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients.
Leung TW; Tang AM; Zee B; Lau WY; Lai PB; Leung KL; Lau JT; Yu SC; Johnson PJ
Cancer; 2002 Mar; 94(6):1760-9. PubMed ID: 11920539
[TBL] [Abstract][Full Text] [Related]
12. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
[TBL] [Abstract][Full Text] [Related]
13. Comparison of seven prognostic staging systems in patients who undergo hepatectomy for hepatocellular carcinoma.
Kondo K; Chijiiwa K; Nagano M; Hiyoshi M; Kai M; Maehara N; Ohuchida J; Nakao H; Ohkuwa Y
Hepatogastroenterology; 2007; 54(77):1534-8. PubMed ID: 17708292
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.
op den Winkel M; Nagel D; Sappl J; op den Winkel P; Lamerz R; Zech CJ; Straub G; Nickel T; Rentsch M; Stieber P; Göke B; Kolligs FT
PLoS One; 2012; 7(10):e45066. PubMed ID: 23071507
[TBL] [Abstract][Full Text] [Related]
15. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score).
Kudo M; Chung H; Osaki Y
J Gastroenterol; 2003; 38(3):207-15. PubMed ID: 12673442
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy.
Seong J; Shim SJ; Lee IJ; Han KH; Chon CY; Ahn SH
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(4):1037-42. PubMed ID: 17234356
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors for survival in patients with hepatocellular carcinoma after radiofrequency ablation].
Lee JH; Han SY; Jo JH; Kim SK; Go BS; Oh JY; Choi JC; Lee SW; Jang JS; Roh MH
Korean J Gastroenterol; 2007 Jan; 49(1):17-23. PubMed ID: 18167429
[TBL] [Abstract][Full Text] [Related]
18. Prognosis predictability of hepatocellular carcinoma according to staging systems in hepatitis B virus-endemic area.
Kang HY; Shin HD; Kim SB; Song IH
Clin Res Hepatol Gastroenterol; 2012 Aug; 36(4):357-64. PubMed ID: 22326248
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of survival of patients with hepatocellular carcinoma: A comparative analysis of prognostic systems.
Tannus RK; Almeida-Carvalho SR; Loureiro-Matos CA; Miziara-Gonzalez A; Salzedas-Netto AA; Szejnfeld D; D'Ippolito G; Pereira-Lanzoni V; Souza-Silva I
PLoS One; 2018; 13(4):e0194922. PubMed ID: 29617435
[TBL] [Abstract][Full Text] [Related]
20. A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma.
Zhang BH; Wang XH; Yue HY; Ling CQ
J Cancer Res Clin Oncol; 2010 Jun; 136(6):821-7. PubMed ID: 19916022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
